Johnson & Johnson
Recent News About Johnson & Johnson View More
-
-
Oklahoma wanted decades of funding from opioid verdict, but will get only one year's worth
NORMAN, Okla. (Legal Newsline) – Oklahoma’s landmark verdict in its opioid case against Johnson & Johnson does not mean the company must pump billions of dollars into the state over the next 30 years, a judge ruled Friday.
-
-
'Wholly inadequate': Lawyers seek more opioid money by avoiding global settlement process
A proposed “negotiation class” to settle all opioid litigation by U.S. cities and counties could be in deep trouble, as the U.S. Court of Appeals for the Sixth Circuit considers an appeal of the order creating the controversial class and lawyers in two states with big claims urge their clients to opt out before a Nov. 22 deadline.
-
New York scores January trial date for its opioid lawsuit
A New York judge has scheduled a Jan. 20 trial for opioid lawsuits by New York State and two counties, setting a short timeline for the companies to settle or face potentially crippling liability.
-
Class action says opioid crisis caused insurance costs to increase, but N.J. court not buying it
TRENTON, N.J. (Legal Newsline) – On Oct. 10, a lawsuit against Johnson & Johnson, Janssen Pharmaceuticals Inc. and Actavis Pharma Inc. was dismissed by the Superior Court of New Jersey’s Law Division in Camden County as the plaintiff failed to prove the opioid crisis was the reason his insurance premium increased.
-
Plaintiffs lawyers welcome judges from litigation hotbeds to conference in Las Vegas
LAS VEGAS (Legal Newsline) – Two judges involved in two of the most high-profile series of legal actions in the country were panelists at a Las Vegas conference organized by plaintiff lawyers.
-
Oklahoma judge admits to $100M mistake in landmark opioid verdict against J&J
NORMAN, Okla. (Legal Newsline) – In a hearing Tuesday to clarify disagreements over a $572 million judgment against Johnson & Johnson for allegedly helping create an opioid epidemic in Oklahoma, attorneys for the state argued more money was needed to fully abate the problem, while lawyers for J&J requested joint liability credits to ease its burden.
-
-
Issues, like bias claims against judge, remain unresolved as bellwether opioid trials approach
CLEVELAND (Legal Newsline) - The remaining defendants facing an Oct. 21 trial in Ohio over opioid claims have asked the U.S. Court of Appeals for the Sixth Circuit to stay proceedings until challenges by the Ohio attorney general and others are concluded.
-
Two recent talc verdicts went against J&J; Both sides vow to keep fighting
LOS ANGELES (Legal Newsline) – Officials for Johnson & Johnson and attorneys representing plaintiffs suing the company for alleged asbestos-tainted baby powder both vowed on Tuesday to continue litigating after two recent verdicts went against the company.
-
'Absolute panic' as cities, counties face deadline on opioid 'negotiation class'
CLEVELAND (Legal Newsline) - Cities and counties are worried and confused as they face a November deadline to join or opt out of an unprecedented “negotiation class” that could determine how much money they get from opioid litigation, a lawyer who represents Texas municipalities said.
-
Companies blamed for addiction crisis attack plaintiffs' case before historic opioid trial
CLEVELAND (Legal Newsline) - Opioid manufacturers and distributors attacked the fundamental allegations in lawsuits by two Ohio counties that are scheduled to begin trial next month, saying they didn’t contribute to the “public nuisance” of opioid abuse and violated no laws by selling their products in Ohio.
-
Jurors won't get confused during huge opioid trial, judge rules; He'll set penalties after
CLEVELAND (Legal Newsline) – A jury will determine who, if anyone, is liable for the nation’s addiction crisis, but the judge overseeing a historic trial will decide how much they would pay.
-
-
Oklahoma judge feeds the 'monster' with $572M opioid ruling against Johnson & Johnson
Sixteen years ago in a case involving gunmaker Sturm, Ruger & Co., a New York appeals court refused to apply public nuisance law against the manufacturer of a legal product, saying that doing so would transform nuisance law “into a monster that would devour in one gulp the entire law of tort.”
-
Johnson & Johnson will appeal $572 million verdict: 'Can't sue your way out of opioid crisis'
“We are disappointed and disagree with the judge's decision. We believe it is flawed,” said attorney Sabrina Strong, a partner at O'Melveny and Myers during a press briefing after the verdict was read.
-
Private lawyers stand to make $90 million as judge hits Johnson & Johnson with $572M opioid ruling
NORMAN, Okla. (Legal Newsline) - A state judge in Oklahoma has blamed Johnson & Johnson for the state's opioid crisis and ordered it to pay $572 million in damages, extending public nuisance law beyond its traditional boundaries into what may become an all-purpose tool for government lawsuits against product manufacturers.
-
Opioid judge, without explanation, rejects claim that 45-defendant mass trial will confuse jurors
CLEVELAND (Legal Newsline) – The federal judge overseeing about 2,000 opioid lawsuits has rejected the argument that his planned seven-week trial will be a free-for-all of evidence and legal theories that will feature dozens of defendants and confused jurors.
-
Opioid judge supports `negotiating class,’ tells critics like state AGs to `come up with a better model’
CLEVELAND (Legal Newsline) - The federal judge overseeing multidistrict litigation against opioid manufacturers and distributors left little doubt he supports a plan developed by private lawyers to assemble an unprecedented “negotiating class” consisting of every city and county in the U.S.